Pneumeric, Inc. has partnered with JP Pharma to distribute the Capnospot® Tension Pneumothorax Decompression Indicator in Brazil. This innovative device provides visual confirmation of needle placement, aiding emergency responders. The partnership aims to enhance medical care in Brazil with cutting-edge technology, reflecting both companies’ commitment to improving health outcomes in critical situations.
Pneumeric, Inc. has formed a significant distribution agreement with JP Pharma, a major tactical medical supplier in Latin America, to provide the life-saving Capnospot® Tension Pneumothorax Decompression Indicator in Brazil. This innovative device facilitates visual validation of proper needle insertion through a simple color change mechanism, enabling emergency responders to undertake additional life-saving treatments swiftly.
With JP Pharma’s extensive portfolio of international medical manufacturers, the introduction of the Capnospot® device aligns seamlessly with both companies’ objectives. The partnership signifies a commitment to elevating medical standards and addressing the needs of emergency staff in Brazil effectively.
Bruno Tavora, Chief Operating Officer of JP Pharma, expressed his enthusiasm for the collaboration, asserting, “I am thrilled about JP Pharma’s new partnership with Pneumeric, a company that shares our passion for innovation in pre-hospital care. I’m confident that this collaboration will help save more lives in our country.”
Deon Miller, Chief Commercial Officer of Pneumeric, Inc., emphasized the potential benefits of this alliance, stating, “We believe this partnership will be mutually beneficial for both companies and look forward to working with JP Pharma to launch the technologically advanced Capnospot into the Brazilian market.”
Pneumeric, Inc., established in 2021, aims to enhance tension pneumothorax care standards while minimizing treatment failures. Boasting FDA clearance and two patents for the Capnospot® device, their commitment to innovation is evident. Additional information can be found at their website.
JP Pharma, founded in 2008, focuses on providing Brazil with the finest medical products available globally. Their strategic partnerships are aimed at equipping emergency responders with advanced medical solutions. For more details, visit their website.
In summary, Pneumeric, Inc. has entered a notable distribution agreement with JP Pharma to introduce the Capnospot® device in Brazil. This partnership aims to enhance emergency response capabilities by providing life-saving technology to medical personnel. The collaboration reflects both organizations’ commitment to improving healthcare outcomes for critical situations, ultimately contributing to increased safety and efficiency in medical emergencies.
Original Source: www.prweb.com
